LACK WALTER J 4
4 · Astex Pharmaceuticals, Inc · Filed Feb 8, 2013
Insider Transaction Report
Form 4
LACK WALTER J
Director
Transactions
- Exercise/Conversion
Director Stock Option (Right to buy)
2013-02-06−2,500→ 0 totalExercise: $3.97Exp: 2016-06-09→ Common Stock (2,500 underlying) - Exercise/Conversion
Director Stock Option (Right to buy)
2013-02-06−10,000→ 0 totalExercise: $2.92Exp: 2021-06-16→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2013-02-06$2.92/sh+10,000$29,200→ 457,500 total - Exercise/Conversion
Director Stock Option (Right to buy)
2013-02-06−15,000→ 0 totalExercise: $2.92Exp: 2021-06-16→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2013-02-06$3.97/sh+2,500$9,925→ 417,500 total - Exercise/Conversion
Common Stock
2013-02-06$3.97/sh+2,500$9,925→ 422,500 total - Exercise/Conversion
Common Stock
2013-02-06$2.92/sh+10,000$29,200→ 447,500 total - Exercise/Conversion
Common Stock
2013-02-06$3.97/sh+2,500$9,925→ 420,000 total - Exercise/Conversion
Common Stock
2013-02-06$2.92/sh+15,000$43,800→ 437,500 total - Exercise/Conversion
Director Stock Option (Right to buy)
2013-02-06−2,500→ 0 totalExercise: $3.97Exp: 2016-06-09→ Common Stock (2,500 underlying) - Exercise/Conversion
Director Stock Option (Right to buy)
2013-02-06−2,500→ 0 totalExercise: $3.97Exp: 2016-06-09→ Common Stock (2,500 underlying) - Exercise/Conversion
Director Stock Option (Right to buy)
2013-02-06−10,000→ 0 totalExercise: $2.92Exp: 2021-06-16→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]2,500 shares of the 10,000 share option grant became exercisable on the June 9, 2006 grant date and on each three month anniversary thereafter.
- [F2]3,750 shares of the 15,000 share option grant became exercisable on the June 16, 2011 grant date and on each three month anniversary therafter.
- [F3]2,500 shares of the 10,000 share option grant became exercisable on the June 16, 2011 grant date and on each three month anniversary thereafter.